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The title salts, C8H13N4
+Cl, (I), and C8H13N4+NO3, (II), contain linked
pyridinium–piperazine heterocycles. In both salts, the piperazine ring adopts a
chair conformation with protonation at the N atom not linked to the other ring.
In the crystal of (I), weak N—H  Cl interactions are observed, leading to
zigzag chains along [100]. In the crystal of (II), both H atoms on the NH2
+ group
form bifurcated N—H  (O,O) hydrogen bonds. Weak C—H  O interactions
are also observed. These bonds collectively link the components into infinite
chains along [100].
1. Chemical context
Pyrimidine-containing compounds exhibit various biological
activities (Goldmann & Stoltefuss, 1991) and related fused
heterocycles are unique classes of heterocyclic compounds
that exhibit a broad spectrum of biological activities such as
anticancer (Amin et al., 2009; Pandey et al., 2004), antiviral
(Ibrahim & El-Metwally, 2010), antibacterial (Kuyper et al.,
1996) and anti-oxidant (Padmaja et al., 2009), antidepressant
(Kim et al., 2010) and possess anti-inflammatory effects (Clark
et al., 2007). In addition, several piperazine derivatives have
reached the stage of clinical application; among the known
drugs that are used to treat anxiety is a pyrimidinylpiperazinyl
compound, buspirone (trade name BuSpar1) (Tollefson et al.,
1991). Our research group has published a number of papers
on incorporated heterocyclic ring structures, viz. imatinibium
dipicrate (Jasinski et al., 2010), 1-(2-hydroxyethyl)-4-[3-(2-
trifluoromethyl-9H-thioxanthen-9-ylidene)propyl]piperazine-
1,4-diium dichloride, which is the dihydrochloride salt of
flupentixol (Siddegowda et al., 2011a) and opipramolium
fumarate (Siddegowda et al., 2011b). Other related crystal
structures are 4-(pyrimidin-2-yl)piperazin-1-ium (E)-3-carb-
oxyprop-2-enoate (Yamuna et al., 2014a), flupentixol tartarate
and enrofloxacinium oxalate (Yamuna et al., 2014b,c). As part
of our ongoing studies in this area, we report herein the crystal
structures of the title salts, (I) and (II).
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2. Structural commentary
The structure of (I) and its atom numbering are shown in
Fig. 1. It consists of a pyrimidylpiperazine cation joined by the
C1/N3 atoms of each unit and a chloride anion. The C1—N3
bond is 1.373 (3) A˚ long, which compares favorably with
similar ionic structures containing this cation [1.369 (3)
(Yamuna et al., 2014a), and 1.36 (6) and 1.37 (1) A˚ (Ding et al.,
2014)]. The N3/C5/C6/N4/C7/C8 piperazine unit adopts a
slightly distorted chair conformation with protonation at the
N4 nitrogen atom. The structure of (II) and its atom
numbering are shown in Fig. 2. Similarly, it consists of a
pyrimidylpiperazine cation joined by the C1/N3 atoms of each
unit and a nitrate anion. The C1—N3 bond is 1.369 (3) A˚, also
in the range of the related structures described above. The N3/
C5/C6/N4/C7/C8 piperazine unit also adopts a slightly
distorted chair conformation with protonation at the N4 atom.
3. Supramolecular features
In the crystal of (I), N4—H4A  Cl1 and N4—H4B  Cl1
interactions are observed between pyrimidylpiperazine
cations and chloride anions, forming zigzag chains along [100]
(Fig. 3 and Table 1). In the crystal of (II), both of the H atoms
on the N4 atom of the pyrimidylpiperazine cation are bifur-
cated, forming N—H  (O,O) hydrogen bonds (Fig. 4 and
Table 2). Additional C—H  O interactions between the
pyrimidyl unit and the nitrate anion are present which, in
concert with the N—H  O hydrogen bonds between the
piperazine group and nitrate anions, form infinite chains along
[100].
4. Database survey
A search of the Cambridge Structural Database (Version 5.35,
last update May 2014: Allen 2002) revealed only three struc-
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Figure 1
ORTEP drawing of C8H13N4
+Cl, (I), showing 30% probability
displacement ellipsoids.
Figure 2
ORTEP drawing of C8H13N4
+NO3, (II), showing 30% probability
displacement ellipsoids.
Figure 3
Molecular packing for C8H13N4
+Cl, (I), viewed along the b axis. Dashed
lines indicate N—H  Cl interactions forming zigzag chains along the a
axis (see Table 1 for details). H atoms not involved in hydrogen bonding
have been omitted for clarity.
Figure 4
Molecular packing for C8H13N4
+NO3, (II), viewed along the c axis.
Dashed lines indicate N—H  O hydrogen bonds and additional C—
H  O interactions forming infinite chains along [100] (see Table 2 for
details). H atoms not involved in hydrogen bonding have been omitted
for clarity.
tures containing the 4-(pyrimidin-2-yl)piperazin-1-ium cation
similar to the structures reported here. These include the salts
of 4-(pyrimidin-2-yl)piperazin-1-ium 3-carboxyprop-2-enoate
(Yamuna et al. 2014a), 4-(pyrimidin-2-yl)piperazin-1-ium
hydrogen d-tartrate monohydrate (Ding et al., 2014) and 4-
(pyrimidin-2-yl)piperazin-1-ium hydrogen l-tartrate mono-
hydrate (Ding et al. 2014). The 3-carboxyprop-2-enoate
complex crystallizes in space group P21/c while the two
hydrogen (D and L)-tartrate monohydrate salts both crystal-
lize in P212121. In comparison, title salt (I) crystallizes in
P212121 while (II) crystallizes in space group P21/c. In addi-
tion, as a related observation, 109 structures containing the
pyrimidine–piperazine unit were also identified in this search.
Some of these include, uniquely, the 4-(pyrimidin-2-yl)piper-




piperazin-1-yl]methanone (Spencer et al., 2011), (E)-1-phenyl-
3-[4-(pyrimidin-2-yl)piperazin-1-yl]propan-1-one oxime (Kol-
asa et al., 2006), N-(4-chlorophenyl)-4-(pyrimidin-2-yl)piper-
azine-1-carboxamide (Li, 2011) and 6-{3-[4-(pyrimidin-2-yl)-
piperazin-1-yl]propyl}-2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyr-
role-5,7(6H)-dione (Bielenica et al., 2011).
5. Synthesis and crystallization
For the preparation of title salt (I), a mixture of 1-(pyrimidin-
2-yl)piperazine (0.2 g) and concentrated hydrochloric acid
(5 ml) was stirred well over a magnetic stirrer at room
temperature for 10 min and then warmed at 313 K for another
10 min. A white precipitate was obtained, which was dried in
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Crystal system, space group Orthorhombic, P212121 Monoclinic, P21/c
Temperature (K) 173 173
a, b, c (A˚) 6.84764 (17), 7.27667 (18), 19.1751 (5) 10.5272 (6), 7.2230 (3), 14.1575 (7)
, ,  () 90, 90, 90 90, 107.341 (6), 90
V (A˚3) 955.46 (4) 1027.58 (9)
Z 4 4
Radiation type Cu K Cu K
 (mm1) 3.21 0.98
Crystal size (mm) 0.26  0.14  0.08 0.22  0.16  0.06
Data collection
Diffractometer Agilent Agilent Eos Gemini Agilent Agilent Eos Gemini
Absorption correction Multi-scan (CrysAlis RED; Agilent, 2012) Multi-scan (CrysAlis RED; Agilent, 2012)
Tmin, Tmax 0.417, 1.000 0.727, 1.000
No. of measured, independent and observed
[I > 2(I)] reflections





R[F 2 > 2(F 2)], wR(F 2), S 0.035, 0.091, 1.08 0.058, 0.163, 1.10
No. of reflections 1841 1960
No. of parameters 119 146
H-atom treatment H-atom parameters constrained H-atom parameters constrained
	max, 	min (e A˚
3) 0.23, 0.20 0.42, 0.25
Absolute structure Flack x determined using 687 quotients
[(I+)(I)]/[(I+)+(I)] (Parsons et al.
(2013)
–
Absolute structure parameter 0.056 (15) –
Computer programs: CrysAlis PRO and CrysAlis RED (Agilent, 2012), SUPERFLIP (Palatinus & Chapuis, 2007), SHELXL2012 (Sheldrick, 2008) and OLEX2 (Dolomanov et al.,
2009).
Table 1
Hydrogen-bond geometry (A˚, ) for (I).
D—H  A D—H H  A D  A D—H  A
N4—H4A  Cl1 0.91 2.21 3.102 (2) 167
N4—H4B  Cl1i 0.91 2.21 3.114 (2) 175
Symmetry code: (i) xþ 12;yþ 32;zþ 1.
Table 2
Hydrogen-bond geometry (A˚, ) for (II).
D—H  A D—H H  A D  A D—H  A
N4—H4A  O2i 0.91 1.92 2.829 (3) 177
N4—H4A  O3i 0.91 2.52 3.138 (3) 126
N4—H4B  O1 0.91 2.35 3.197 (3) 155
N4—H4B  O2 0.91 2.10 2.900 (3) 146
C3—H3  O1ii 0.95 2.46 3.240 (3) 140
C4—H4  O2iii 0.95 2.51 3.291 (3) 139
Symmetry codes: (i) xþ 1; y 12;zþ 12; (ii) x;yþ 1;zþ 1; (iii) x 1; y; z.
the open air overnight and then dissolved in hot dimethyl
sulfoxide solvent. After few days, colourless blocks were
obtained on slow evaporation (m.p. above 563 K).
For the preparation of title salt (II), a mixture of 1-
(pyrimidin-2-yl)piperazine, from Sigma–Aldrich (0.2 g), and
concentrated nitric acid (5 ml) was stirred well over a
magnetic stirrer at room temperature for 10 min. A white
precipitate was obtained immediately, which was dried in the
open air overnight and then dissolved in water. After a few
days, colourless blocks were obtained on slow evaporation
(m.p. 463–470 K).
6. Refinement
Crystal data, data collection and structure refinement details
are summarized in Table 3. In both (I) and (II), all of the H
atoms were placed in their calculated positions and then
refined using a riding model with C—H bond lengths of 0.93
(CH) or 0.97 A˚ (CH2) and N—H bond lengths of 0.97 A˚.
Isotropic displacement parameters for these atoms were set at
1.2Ueq(CH,CH2,NH).
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Crystal structures of 4-(pyrimidin-2-yl)piperazin-1-ium chloride and 
4-(pyrimidin-2-yl)piperazin-1-ium nitrate
Thammarse S. Yamuna, Jerry P. Jasinski, Manpreet Kaur, Brian J. Anderson and H. S. Yathirajan
Computing details 
For both compounds, data collection: CrysAlis PRO (Agilent, 2012); cell refinement: CrysAlis PRO (Agilent, 2012); data 
reduction: CrysAlis RED (Agilent, 2012); program(s) used to solve structure: SUPERFLIP (Palatinus & Chapuis, 2007); 
program(s) used to refine structure: SHELXL2012 (Sheldrick, 2008); molecular graphics: OLEX2 (Dolomanov et al., 
2009); software used to prepare material for publication: OLEX2 (Dolomanov et al., 2009).





a = 6.84764 (17) Å
b = 7.27667 (18) Å
c = 19.1751 (5) Å
V = 955.46 (4) Å3
Z = 4
F(000) = 424
Dx = 1.395 Mg m−3
Cu Kα radiation, λ = 1.54184 Å
Cell parameters from 2676 reflections
θ = 4.6–71.5°
µ = 3.21 mm−1
T = 173 K
Irregular, colourless
0.26 × 0.14 × 0.08 mm
Data collection 
Agilent Agilent Eos Gemini 
diffractometer
Radiation source: Enhance (Cu) X-ray Source
Detector resolution: 16.0416 pixels mm-1
ω scans
Absorption correction: multi-scan 
(CrysAlis RED; Agilent, 2012)
Tmin = 0.417, Tmax = 1.000
5514 measured reflections
1841 independent reflections
1761 reflections with I > 2σ(I)
Rint = 0.045













Primary atom site location: structure-invariant 
direct methods
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.0504P)2 + 0.1163P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.23 e Å−3
Δρmin = −0.20 e Å−3
Extinction correction: SHELXL2012 (Sheldrick, 
2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Extinction coefficient: 0.0073 (13)
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Absolute structure: Flack x determined using 
687 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al. 
(2013)
Absolute structure parameter: 0.056 (15)
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
Cl1 0.08383 (9) 0.49612 (9) 0.48653 (3) 0.0262 (2)
N1 0.6948 (4) 0.6820 (3) 0.81551 (12) 0.0251 (5)
N2 0.9664 (4) 0.5690 (3) 0.74930 (13) 0.0286 (6)
N3 0.6688 (3) 0.6293 (3) 0.69659 (12) 0.0224 (5)
N4 0.4359 (4) 0.6322 (3) 0.57422 (12) 0.0258 (5)
H4A 0.3467 0.5800 0.5451 0.031*
H4B 0.4718 0.7422 0.5556 0.031*
C1 0.7813 (4) 0.6281 (4) 0.75588 (14) 0.0208 (5)
C2 0.8040 (4) 0.6746 (4) 0.87274 (15) 0.0269 (6)
H2 0.7471 0.7097 0.9159 0.032*
C3 0.9968 (5) 0.6181 (4) 0.87217 (16) 0.0318 (7)
H3 1.0742 0.6147 0.9133 0.038*
C4 1.0692 (5) 0.5668 (4) 0.80773 (17) 0.0330 (7)
H4 1.2013 0.5274 0.8052 0.040*
C5 0.7582 (4) 0.5944 (4) 0.62855 (14) 0.0245 (6)
H5A 0.8701 0.5096 0.6341 0.029*
H5B 0.8076 0.7111 0.6088 0.029*
C6 0.6103 (4) 0.5108 (4) 0.57949 (14) 0.0278 (6)
H6A 0.6694 0.4948 0.5328 0.033*
H6B 0.5705 0.3883 0.5969 0.033*
C7 0.3448 (4) 0.6631 (4) 0.64394 (14) 0.0246 (6)
H7A 0.2964 0.5449 0.6628 0.030*
H7B 0.2323 0.7475 0.6392 0.030*
C8 0.4936 (4) 0.7449 (4) 0.69357 (14) 0.0233 (6)
H8A 0.5297 0.8698 0.6777 0.028*
H8B 0.4359 0.7553 0.7407 0.028*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
Cl1 0.0230 (3) 0.0300 (4) 0.0255 (3) −0.0007 (3) −0.0033 (2) 0.0015 (3)
N1 0.0252 (12) 0.0254 (11) 0.0246 (11) −0.0008 (10) −0.0007 (10) −0.0015 (9)
N2 0.0240 (14) 0.0310 (12) 0.0309 (12) 0.0064 (10) 0.0001 (10) 0.0014 (10)
N3 0.0184 (11) 0.0255 (11) 0.0233 (11) 0.0044 (9) 0.0015 (9) −0.0022 (10)
N4 0.0228 (12) 0.0290 (11) 0.0256 (11) −0.0051 (10) −0.0032 (10) 0.0005 (10)
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C1 0.0217 (13) 0.0157 (11) 0.0251 (13) 0.0000 (10) 0.0013 (11) 0.0022 (10)
C2 0.0342 (16) 0.0238 (13) 0.0229 (13) −0.0013 (12) 0.0000 (12) −0.0001 (11)
C3 0.0353 (16) 0.0287 (14) 0.0314 (14) −0.0017 (14) −0.0114 (14) 0.0056 (12)
C4 0.0238 (14) 0.0339 (14) 0.0413 (17) 0.0072 (13) −0.0056 (14) 0.0062 (13)
C5 0.0208 (13) 0.0292 (14) 0.0233 (13) 0.0030 (11) 0.0031 (11) −0.0032 (11)
C6 0.0256 (14) 0.0316 (14) 0.0261 (13) 0.0000 (14) 0.0035 (10) −0.0058 (12)
C7 0.0200 (13) 0.0272 (13) 0.0267 (14) −0.0009 (11) −0.0007 (11) 0.0007 (11)
C8 0.0186 (13) 0.0244 (12) 0.0268 (13) 0.0046 (12) −0.0004 (12) −0.0027 (11)
Geometric parameters (Å, º) 
N1—C1 1.346 (4) C3—H3 0.9500
N1—C2 1.329 (4) C3—C4 1.383 (4)
N2—C1 1.344 (4) C4—H4 0.9500
N2—C4 1.323 (4) C5—H5A 0.9900
N3—C1 1.373 (3) C5—H5B 0.9900
N3—C5 1.463 (3) C5—C6 1.510 (4)
N3—C8 1.466 (3) C6—H6A 0.9900
N4—H4A 0.9100 C6—H6B 0.9900
N4—H4B 0.9100 C7—H7A 0.9900
N4—C6 1.489 (4) C7—H7B 0.9900
N4—C7 1.492 (3) C7—C8 1.516 (4)
C2—H2 0.9500 C8—H8A 0.9900
C2—C3 1.383 (4) C8—H8B 0.9900
C2—N1—C1 116.2 (2) N3—C5—H5B 109.6
C4—N2—C1 115.2 (3) N3—C5—C6 110.2 (2)
C1—N3—C5 120.2 (2) H5A—C5—H5B 108.1
C1—N3—C8 119.7 (2) C6—C5—H5A 109.6
C5—N3—C8 114.0 (2) C6—C5—H5B 109.6
H4A—N4—H4B 108.0 N4—C6—C5 110.0 (2)
C6—N4—H4A 109.4 N4—C6—H6A 109.7
C6—N4—H4B 109.4 N4—C6—H6B 109.7
C6—N4—C7 111.3 (2) C5—C6—H6A 109.7
C7—N4—H4A 109.4 C5—C6—H6B 109.7
C7—N4—H4B 109.4 H6A—C6—H6B 108.2
N1—C1—N3 117.0 (2) N4—C7—H7A 109.7
N2—C1—N1 126.0 (2) N4—C7—H7B 109.7
N2—C1—N3 116.9 (2) N4—C7—C8 109.9 (2)
N1—C2—H2 118.6 H7A—C7—H7B 108.2
N1—C2—C3 122.9 (3) C8—C7—H7A 109.7
C3—C2—H2 118.6 C8—C7—H7B 109.7
C2—C3—H3 122.3 N3—C8—C7 110.4 (2)
C2—C3—C4 115.5 (3) N3—C8—H8A 109.6
C4—C3—H3 122.3 N3—C8—H8B 109.6
N2—C4—C3 124.2 (3) C7—C8—H8A 109.6
N2—C4—H4 117.9 C7—C8—H8B 109.6
C3—C4—H4 117.9 H8A—C8—H8B 108.1
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N3—C5—H5A 109.6
N1—C2—C3—C4 −0.8 (4) C4—N2—C1—N1 −0.6 (4)
N3—C5—C6—N4 55.8 (3) C4—N2—C1—N3 −178.9 (3)
N4—C7—C8—N3 −54.5 (3) C5—N3—C1—N1 172.5 (2)
C1—N1—C2—C3 1.0 (4) C5—N3—C1—N2 −9.0 (4)
C1—N2—C4—C3 0.8 (4) C5—N3—C8—C7 55.2 (3)
C1—N3—C5—C6 151.9 (2) C6—N4—C7—C8 57.4 (3)
C1—N3—C8—C7 −152.4 (2) C7—N4—C6—C5 −58.1 (3)
C2—N1—C1—N2 −0.3 (4) C8—N3—C1—N1 21.8 (4)
C2—N1—C1—N3 178.0 (2) C8—N3—C1—N2 −159.8 (2)
C2—C3—C4—N2 −0.2 (5) C8—N3—C5—C6 −55.8 (3)
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A
N4—H4A···Cl1 0.91 2.21 3.102 (2) 167
N4—H4B···Cl1i 0.91 2.21 3.114 (2) 175
Symmetry code: (i) x+1/2, −y+3/2, −z+1.





a = 10.5272 (6) Å
b = 7.2230 (3) Å
c = 14.1575 (7) Å
β = 107.341 (6)°
V = 1027.58 (9) Å3
Z = 4
F(000) = 480
Dx = 1.469 Mg m−3
Cu Kα radiation, λ = 1.54184 Å
Cell parameters from 2763 reflections
θ = 6.2–71.4°
µ = 0.98 mm−1
T = 173 K
Irregular, colourless
0.22 × 0.16 × 0.06 mm
Data collection 
Agilent Agilent Eos Gemini 
diffractometer
Radiation source: Cu Kα
Detector resolution: 16.0416 pixels mm-1
ω scans
Absorption correction: multi-scan 
(CrysAlis RED; Agilent, 2012)
Tmin = 0.727, Tmax = 1.000
6218 measured reflections
1960 independent reflections
1752 reflections with I > 2σ(I)
Rint = 0.040













Primary atom site location: structure-invariant 
direct methods
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.0789P)2 + 0.9595P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
supporting information
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Δρmax = 0.42 e Å−3
Δρmin = −0.25 e Å−3
Extinction correction: SHELXL2012 (Sheldrick, 
2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Extinction coefficient: 0.0099 (14)
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
O1 0.4119 (2) 0.6964 (4) 0.41222 (17) 0.0615 (7)
O2 0.50951 (18) 0.6257 (2) 0.30424 (14) 0.0381 (5)
O3 0.55020 (17) 0.8884 (2) 0.37996 (13) 0.0323 (5)
N5 0.49103 (17) 0.7390 (3) 0.36677 (13) 0.0238 (4)
N1 0.00592 (19) 0.2396 (3) 0.48106 (14) 0.0291 (5)
N2 −0.11846 (18) 0.3821 (3) 0.32856 (15) 0.0273 (5)
N3 0.10930 (18) 0.3372 (3) 0.36702 (14) 0.0268 (5)
N4 0.33344 (18) 0.3134 (3) 0.29632 (15) 0.0278 (5)
H4A 0.3814 0.2536 0.2617 0.033*
H4B 0.3777 0.4191 0.3216 0.033*
C1 −0.0049 (2) 0.3204 (3) 0.39365 (16) 0.0220 (5)
C2 −0.1085 (3) 0.2126 (3) 0.50188 (19) 0.0346 (6)
H2 −0.1054 0.1544 0.5627 0.042*
C3 −0.2307 (2) 0.2647 (4) 0.4398 (2) 0.0362 (6)
H3 −0.3111 0.2420 0.4553 0.043*
C4 −0.2290 (2) 0.3519 (3) 0.3537 (2) 0.0329 (6)
H4 −0.3113 0.3927 0.3097 0.039*
C5 0.2387 (2) 0.2876 (4) 0.43489 (16) 0.0282 (5)
H5A 0.2266 0.2035 0.4867 0.034*
H5B 0.2848 0.4005 0.4676 0.034*
C6 0.3222 (2) 0.1932 (3) 0.37877 (17) 0.0270 (5)
H6A 0.4121 0.1674 0.4242 0.032*
H6B 0.2808 0.0738 0.3519 0.032*
C7 0.1993 (2) 0.3620 (3) 0.22801 (17) 0.0277 (5)
H7A 0.1537 0.2483 0.1960 0.033*
H7B 0.2095 0.4461 0.1755 0.033*
C8 0.1166 (2) 0.4552 (3) 0.28517 (17) 0.0276 (5)
H8A 0.1571 0.5756 0.3112 0.033*
H8B 0.0258 0.4789 0.2407 0.033*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O1 0.0614 (14) 0.0836 (17) 0.0562 (13) −0.0362 (13) 0.0431 (11) −0.0184 (12)
O2 0.0436 (10) 0.0314 (10) 0.0460 (11) −0.0072 (8) 0.0238 (8) −0.0153 (8)
O3 0.0379 (9) 0.0249 (9) 0.0353 (9) −0.0045 (7) 0.0129 (7) −0.0021 (7)
supporting information
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N5 0.0175 (9) 0.0301 (10) 0.0240 (9) −0.0015 (7) 0.0064 (7) 0.0012 (8)
N1 0.0292 (10) 0.0327 (11) 0.0282 (10) 0.0020 (8) 0.0126 (8) 0.0038 (8)
N2 0.0210 (9) 0.0270 (10) 0.0331 (11) 0.0037 (7) 0.0071 (8) 0.0001 (8)
N3 0.0189 (9) 0.0380 (11) 0.0243 (9) 0.0068 (8) 0.0075 (7) 0.0087 (8)
N4 0.0231 (9) 0.0278 (10) 0.0368 (11) −0.0042 (8) 0.0153 (8) −0.0045 (8)
C1 0.0207 (10) 0.0220 (10) 0.0246 (11) 0.0023 (8) 0.0087 (8) −0.0035 (8)
C2 0.0416 (14) 0.0328 (13) 0.0372 (13) −0.0021 (11) 0.0235 (11) −0.0014 (10)
C3 0.0300 (13) 0.0340 (13) 0.0525 (15) −0.0049 (10) 0.0247 (11) −0.0130 (12)
C4 0.0224 (11) 0.0304 (12) 0.0456 (15) 0.0020 (9) 0.0098 (10) −0.0063 (11)
C5 0.0208 (11) 0.0395 (13) 0.0234 (11) 0.0087 (9) 0.0054 (9) 0.0023 (9)
C6 0.0219 (10) 0.0296 (12) 0.0293 (11) 0.0038 (9) 0.0074 (9) 0.0014 (9)
C7 0.0291 (11) 0.0305 (12) 0.0255 (11) −0.0013 (9) 0.0111 (9) 0.0039 (9)
C8 0.0267 (11) 0.0290 (12) 0.0283 (11) 0.0033 (9) 0.0098 (9) 0.0080 (9)
Geometric parameters (Å, º) 
O1—N5 1.233 (3) C2—C3 1.376 (4)
O2—N5 1.263 (2) C3—H3 0.9500
O3—N5 1.232 (2) C3—C4 1.377 (4)
N1—C1 1.342 (3) C4—H4 0.9500
N1—C2 1.337 (3) C5—H5A 0.9900
N2—C1 1.349 (3) C5—H5B 0.9900
N2—C4 1.333 (3) C5—C6 1.512 (3)
N3—C1 1.369 (3) C6—H6A 0.9900
N3—C5 1.459 (3) C6—H6B 0.9900
N3—C8 1.459 (3) C7—H7A 0.9900
N4—H4A 0.9100 C7—H7B 0.9900
N4—H4B 0.9100 C7—C8 1.512 (3)
N4—C6 1.487 (3) C8—H8A 0.9900
N4—C7 1.496 (3) C8—H8B 0.9900
C2—H2 0.9500
O1—N5—O2 118.2 (2) C3—C4—H4 118.2
O3—N5—O1 121.9 (2) N3—C5—H5A 109.7
O3—N5—O2 119.82 (18) N3—C5—H5B 109.7
C2—N1—C1 115.6 (2) N3—C5—C6 109.86 (18)
C4—N2—C1 115.5 (2) H5A—C5—H5B 108.2
C1—N3—C5 121.45 (19) C6—C5—H5A 109.7
C1—N3—C8 121.92 (18) C6—C5—H5B 109.7
C5—N3—C8 114.01 (18) N4—C6—C5 110.12 (18)
H4A—N4—H4B 108.0 N4—C6—H6A 109.6
C6—N4—H4A 109.4 N4—C6—H6B 109.6
C6—N4—H4B 109.4 C5—C6—H6A 109.6
C6—N4—C7 111.33 (17) C5—C6—H6B 109.6
C7—N4—H4A 109.4 H6A—C6—H6B 108.2
C7—N4—H4B 109.4 N4—C7—H7A 109.7
N1—C1—N2 126.0 (2) N4—C7—H7B 109.7
N1—C1—N3 116.88 (19) N4—C7—C8 109.99 (18)
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N2—C1—N3 117.06 (19) H7A—C7—H7B 108.2
N1—C2—H2 118.3 C8—C7—H7A 109.7
N1—C2—C3 123.4 (2) C8—C7—H7B 109.7
C3—C2—H2 118.3 N3—C8—C7 109.85 (18)
C2—C3—H3 122.1 N3—C8—H8A 109.7
C2—C3—C4 115.8 (2) N3—C8—H8B 109.7
C4—C3—H3 122.1 C7—C8—H8A 109.7
N2—C4—C3 123.6 (2) C7—C8—H8B 109.7
N2—C4—H4 118.2 H8A—C8—H8B 108.2
N1—C2—C3—C4 −1.3 (4) C4—N2—C1—N1 −2.7 (3)
N3—C5—C6—N4 55.5 (3) C4—N2—C1—N3 175.4 (2)
N4—C7—C8—N3 −55.3 (2) C5—N3—C1—N1 −6.3 (3)
C1—N1—C2—C3 −0.7 (4) C5—N3—C1—N2 175.4 (2)
C1—N2—C4—C3 0.2 (3) C5—N3—C8—C7 56.9 (3)
C1—N3—C5—C6 141.1 (2) C6—N4—C7—C8 56.9 (2)
C1—N3—C8—C7 −141.2 (2) C7—N4—C6—C5 −57.0 (2)
C2—N1—C1—N2 2.9 (3) C8—N3—C1—N1 −166.9 (2)
C2—N1—C1—N3 −175.2 (2) C8—N3—C1—N2 14.8 (3)
C2—C3—C4—N2 1.6 (4) C8—N3—C5—C6 −57.0 (3)
Hydrogen-bond geometry (Å, º) 
D—H···A D—H H···A D···A D—H···A
N4—H4A···O2i 0.91 1.92 2.829 (3) 177
N4—H4A···O3i 0.91 2.52 3.138 (3) 126
N4—H4B···O1 0.91 2.35 3.197 (3) 155
N4—H4B···O2 0.91 2.10 2.900 (3) 146
C3—H3···O1ii 0.95 2.46 3.240 (3) 140
C4—H4···O2iii 0.95 2.51 3.291 (3) 139
Symmetry codes: (i) −x+1, y−1/2, −z+1/2; (ii) −x, −y+1, −z+1; (iii) x−1, y, z.
